CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

Abstract Background Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. Specific and thorough identification of cancer cell subsets with higher tumorigenicity and chemoresistance, such as cancer stem cells (CSCs), could lead to the development of new and promising therapeutic...

Full description

Bibliographic Details
Main Authors:	Angel A. Gómez-Gallegos, Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Elizabeth Pérez-Islas, Zuly J. Hernandez-Peralta, Mariel E. Toledo-Guzmán, Alejandro García-Carrancá, Elizabeth Langley, Angélica Hernández-Guerrero, Fernando López-Casillas, Roberto Herrera-Goepfert, Luis F. Oñate-Ocaña, Elizabeth Ortiz-Sánchez
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Series:	Stem Cell Research & Therapy
Subjects:	Gastric cancer Cancer stem cells Immunophenotype Metastasis Zebrafish Xenotransplants
Online Access:	https://doi.org/10.1186/s13287-023-03241-7

Similar Items

Childhood acute lymphoblastic leukemia: Immunophenotypic profile and aberrant expression of CD13, CD33, CD117, CD11b, CD16, and CD64
by: Ihsan Mardan Al-Badran, et al.
Published: (2022-01-01)

EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAMhigh/CD44+ colorectal cancer stem cells
by: Qi Yanmei, et al.
Published: (2022-07-01)

CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
by: Guillaume Belthier, et al.
Published: (2021-10-01)

ZFTool: A Software for Automatic Quantification of Cancer Cell Mass Evolution in Zebrafish
by: María J. Carreira, et al.
Published: (2021-08-01)

Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer
by: Zhengwei Leng, et al.
Published: (2018-03-01)

Circulating CD45+EpCAM+ cells as a diagnostic marker for early-stage primary lung cancer
by: Zhen Sun, et al.
Published: (2022-09-01)

DIFFERENTIATED EFFECTS OF GLUCOSAMINYLMURAMILDIPEPTIDE ON THE NONTRANSFORMED AND EXPERIMENTALLY TRANSFORMED PHENOTYPE OF CD62L+CD63+CD66d+ NEUTROPHILIC GRANULOCYTES IN CONVENTIONALLY HEALTHY PEOPLE
by: I. V. Nesterova, et al.
Published: (2018-12-01)

Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer
by: Ellinor I. Peerschke, et al.
Published: (2020-10-01)

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
by: Emily Maria Ploeg, et al.
Published: (2023-07-01)

The Ultrastructural Analysis of Human Colorectal Cancer Stem Cell-Derived Spheroids and Their Mouse Xenograft Shows That the Same Cells Types Have Different Ratios
by: Michela Relucenti, et al.
Published: (2021-09-01)

Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
by: Rimma Laufer Britva, et al.
Published: (2023-03-01)

CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy
by: Benita C. Y. Tse, et al.
Published: (2023-12-01)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
by: Elham Kalantari, et al.
Published: (2022-01-01)

A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM<sup>−</sup>/CD133<sup>−</sup> nonStem Cells into EpCAM<sup>+</sup>/CD133<sup>+</sup> Liver Cancer Stem Cells in HCC Cell Line HuH7
by: Zeynep Firtina Karagonlar, et al.
Published: (2020-05-01)

Gene Modification in Non-Human Animal for Developing Human Compatible Organs: Ethical, Legal, Clinical and Societal Issues
by: Arif Jamil, et al.
Published: (2023-06-01)

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
by: Vita Golubovskaya, et al.
Published: (2023-05-01)

Radiomic models based on magnetic resonance imaging predict the spatial distribution of CD8+ tumor-infiltrating lymphocytes in breast cancer
by: Seung Hyuck Jeon, et al.
Published: (2022-12-01)

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
by: Hoe, S.L.L., et al.
Published: (2017)

CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis
by: Mariana Nobre Farias de Franca, et al.
Published: (2024-02-01)

Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review
by: Beatriz E. Sarmiento, et al.
Published: (2022-04-01)

Enhancing Prediction Performance by Add-On Combining Circulating Tumor Cell Count, CD45<sup>neg</sup> EpCAM<sup>neg</sup> Cell Count on Colorectal Cancer, Advance, and Metastasis
by: Sherry Yueh-Hsia Chiu, et al.
Published: (2021-05-01)

EVALUATION OF INTERDEPENDENCE BETWEEN γδT-CELL LEVELS AND CD3+CD4+ T-LYMPHOCYTE CONTENTS IN HIV-INFECTED PATIENTS
by: A. V. Zurochka, et al.
Published: (2014-07-01)

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by: Mesude Falay, et al.
Published: (2018-05-01)

Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma
by: Nobuhiko Asakura, et al.
Published: (2021-08-01)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

The Characterization of Cardiac Explants Reveals Unique Fibrosis Patterns and a Predominance of CD8+ T Cell Subpopulations in Patients with Chronic Chagas Cardiomyopathy
by: Martha Lucía Díaz, et al.
Published: (2022-11-01)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
by: Takeshi Ouchi, et al.
Published: (2021-01-01)

Primary pelvic floor reconstruction after pelvic evisceration with “Collost” membranes
by: Z. Z. Mamedli, et al.
Published: (2016-10-01)

The Expression Levels of CD20 as a Prognostic Value in Feline B-Cell Nasal Lymphoma: A Pilot Study
by: Kravee Chaipoca, et al.
Published: (2024-03-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

CD39+ REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN'S SYNDROME
by: Igor Vladimirovich Kudryavtsev, et al.
Published: (2019-03-01)

Human Nanoplatelets as Living Vehicles for Tumor-Targeted Endocytosis In Vitro and Imaging In Vivo
by: Lu Dai, et al.
Published: (2023-02-01)

The history of cardiac xenotransplantation: early attempts, major advances, and current progress
by: Nicholas R. Hess, et al.
Published: (2023-07-01)

Early CAR− CD4+ T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma
by: Massimiliano Gambella, et al.
Published: (2024-04-01)

Flow cytometry principles for clinical laboratory practice : quality assurance for quantitative immunophenotyping /
by: 409867 Owens, Marilyn A., et al.
Published: (1995)

Prognostic Significance of <i>TWIST1</i>, <i>CD24</i>, <i>CD44</i>, and <i>ALDH1</i> Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
by: Areti Strati, et al.
Published: (2019-06-01)

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
by: No-Joon Song, et al.
Published: (2022-01-01)

How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen
by: José Cabeçadas, et al.
Published: (2021-11-01)

The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
by: Hanaan Kareem Al-Zubaidi, et al.
Published: (2023-09-01)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
by: Tianqi Liang, et al.
Published: (2022-12-01)